Paul D Depriest

Title: Paul D Depriest: Innovator in Ovarian Cancer Biomarkers

Introduction

Paul D Depriest is a notable inventor based in Versailles, Kentucky, who has made significant contributions to the field of medical diagnostics. His work primarily focuses on developing biomarkers for ovarian cancer, which can greatly enhance the accuracy of cancer diagnosis and treatment.

Latest Patents

One of his key patents is titled "Biomarkers for Ovarian Cancer." This invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. The biomarkers developed by Depriest can classify a subject sample as ovarian cancer, ovarian cancer of low malignant potential, benign ovarian disease, or other malignant conditions. These biomarkers can be detected using SELDI mass spectrometry, offering a promising tool for early detection and diagnosis.

Career Highlights

Throughout his career, Paul D Depriest has worked with reputable organizations, including Vermillion Corporation and the University of Kentucky Research Foundation. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to advancements in cancer research.

Collaborations

Some of his notable coworkers include Eric Thomas Fung and Frederick R Ueland, who have also played significant roles in the research and development of cancer biomarkers.

Conclusion

Paul D Depriest's innovative work in the field of ovarian cancer biomarkers exemplifies the impact of research and invention on medical diagnostics. His contributions are vital for improving patient outcomes and advancing cancer research.